News | March 16, 2012

Canada Clears Boston Scientific’s Blazer Open-Irrigation Ablation Catheter

March 16, 2012 — Boston Scientific Corp. announced Health Canada approval of the Blazer open-irrigated catheter, the company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation (AF), atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product will be launched immediately in Canada.

The Blazer open-irrigated catheter integrates Total Tip Cooling design with the high-performance Blazer catheter platform. The Total Tip Cooling design consistently cools the entire tip electrode during radiofrequency (RF) energy delivery, resulting in reduced coagulum at the proximal edges of the tip. This is achieved through both internal cooling and external washing of the tip electrode.

"The excellent cooling profile, coupled with the high performance Blazer platform, makes this catheter an important additional option for performing simple and complex ablations," said Felix Ayala-Parades, M.D., chief electrophysiologist at Sherbrooke University Hospital Centre in Quebec, who performed the first procedure in Canada using the Blazer open-irrigated catheter with Santiago Rivera, M.D. "The tip temperatures were lower than conventional open-irrigated catheters during RF delivery. The catheter handling also allowed for a smooth drag lesion to be created without any gaps in the lesion set and with good contact to ensure adequate lesion creation."

AF is a rapid irregular rhythm affecting the upper chambers of the heart. Patients are most often treated with anti-arrhythmic drugs, which can be associated with adverse side effects. Cardiac ablation with an radiofrequency ablation (RFA) catheter is being used increasingly for patients who cannot tolerate these medications.

"The Health Canada approval and launch of the Blazer open-irrigated catheter in Canada are important milestones in our continued focus on advancing cardiac ablation technology," said Hank Kucheman, CEO of Boston Scientific. "We are committed to expanding our Canadian electrophysiology business and improving outcomes for patients undergoing cardiac ablation procedures."

In the United States, the blazer open-irrigated catheter is an investigational device, limited by applicable law to investigational use only and not available for sale. The product is approved for use in CE mark countries.

For more information: www.bostonscientific.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init